Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ahmet Sevindik

Advertisement
Set Alert for Articles By Ahmet Sevindik

Latest From Ahmet Sevindik

Turkish Medtech Industry Demands More Support From The Government

Medical device companies, particularly SMEs, are having a tough time in accessing the local market in Turkey and on being paid enough once they get there. Kemal Yaz, president of the Federation of the Medical Device Manufacturers’ and Suppliers’ Association (TUMDEF), spoke to Medtech Insight about local manufacturers’ problems and expectations.

Turkey Market Access

Turkey’s $10Bn Medtech Tender Must Come With Export And Local IP Elements

Turkey’s health ministry has disclosed that the forthcoming $10bn medical device tender must come with conditions that strengthen the local manufacturing infrastructure. It must also give Turkey “real” technology with IP rights, not merely an assembly activity for parts manufactured abroad. The tender will be ready in some two to three months.

Turkey Policy

EU Files WTO Complaint Against Turkey's Pharma Production Policy

The EU has filed a complaint at the WTO against Turkey’s localization policy, which forces multinational pharmaceutical companies to produce medicines in Turkey. Industry sources say the EU may not get what it wants.

Turkey EU

Interview: Head Of Turkish Industry Body Highlights Key Challenges In 2019

Production localization and the fixed rate set for the euro against the lira will be key topics for the pharma industry in Turkey this year, with the expected further devaluation of the domestic currency likely to inflict more damage on companies. Turgut Tokgöz, secretary general of the Turkish industry association, spoke to Scrip.

Turkey Trade

Turkey’s New Fixed Euro Rate Spells More Pressure For Industry

The Turkish government has set the fixed Euro rate to calculate drug prices at TRY3.40 for 2019.

Pricing Debate Turkey

Turkey Braces For More Drug Access Problems As New Fixed Euro Rate Nears

With the Turkish medicine shortage situation as bad as ever, the national pharmacists’ association has said that 521 products are now “hard to find,” while 141 are unavailable. A government move to adjust the fixed euro rate on which drug prices are calculated is not expected to do much to solve the problem.

Pricing Debate Turkey
See All
Advertisement
UsernamePublicRestriction

Register